{"celex_id": "32006R1451", "uri": "http://publications.europa.eu/resource/cellar/5b1c6f97-8f81-4d49-9f9b-0f87845bef9e", "type": "Regulation", "concepts": ["1442", "1598", "2737", "343", "5734"], "title": "Commission Regulation (EC) No 1451/2006 of 29 September 2006 amending Annexes I and II to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, as regards fluazuron, sodium nitrite and peforelin   (Text with EEA relevance)\n", "header": "30.9.2006 EN Official Journal of the European Union L 271/37\nCOMMISSION REGULATION (EC) No 1451/2006\nof 29 September 2006\namending Annexes I and II to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, as regards fluazuron, sodium nitrite and peforelin\n(Text with EEA relevance)\nTHE COMMISSION OF THE EUROPEAN COMMUNITIES", "recitals": ",\nHaving regard to the Treaty establishing the European Community,\nHaving regard to Council Regulation (EEC) No 2377/90 of 26 June 1990 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin\u00a0(1), and in particular Articles 2 and 3 thereof,\nHaving regard to the opinions of the European Medicines Agency formulated by the Committee for Medicinal Products for Veterinary Use,\nWhereas:\n(1) All pharmacologically active substances used in the Community in veterinary medicinal products intended for food-producing animals should be evaluated in accordance with Regulation (EEC) No 2377/90.\n(2) The substance fluazuron is included in Annex III to Regulation (EEC) No 2377/90 for bovine for muscle, fat, liver and kidney, excluding animals from which milk is produced for human consumption. Additional data were provided and assessed leading to the recommendation that fluazuron should be included in Annex I to Regulation (EEC) No 2377/90 for bovine for muscle, fat, liver and kidney, excluding animals from which milk is produced for human consumption.\n(3) Following examination of an application for the establishment of maximum residue limits for sodium nitrite in dairy cattle, it is considered appropriate to include this substance in Annex II to Regulation (EEC) No 2377/90 for the bovine species for topical use only.\n(4) Following examination of an application for the establishment of maximum residue limits for peforelin in porcine species, it is considered appropriate to include this substance in Annex II to Regulation (EEC) No 2377/90 for the porcine species.\n(5) Regulation (EEC) No 2377/90 should therefore be amended accordingly.\n(6) An adequate period should be allowed before the applicability of this Regulation in order to enable Member States to make any adjustment which may be necessary in the light of this Regulation to the authorisations to place the veterinary medicinal products concerned on the market which have been granted in accordance with Directive 2001/82/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to veterinary medicinal products\u00a0(2) to take account of the provisions of this Regulation.\n(7) The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Veterinary Medicinal Products,", "main_body": ["Annexes I and II to Regulation (EEC) No 2377/90 are amended in accordance with the Annex to this Regulation.", "This Regulation shall enter into force on the third day following its publication in the Official Journal of the European Union.\nIt shall apply from 29 November 2006.\nThis Regulation shall be binding in its entirety and directly applicable in all Member States."], "attachments": "Done at Brussels, 29 September 2006.\nFor the Commission\nG\u00fcnter VERHEUGEN\nVice-President\n(1)\u00a0\u00a0OJ L 224, 18.8.1990, p. 1. Regulation as last amended by Commission Regulation (EC) No 1231/2006 (OJ L 225, 17.8.2006, p. 3).\n(2)\u00a0\u00a0OJ L 311, 28.11.2001, p. 1. Directive as last amended by Directive 2004/28/EC (OJ L 136, 30.4.2004, p. 58).\nANNEX\nA.\u00a0\u00a0\u00a0The following substance is inserted in Annex I to Regulation (EEC) No 2377/90:\n2.\u00a0\u00a0\u00a0Anti-parasitic agents\n2.2.\u00a0\u00a0\u00a0Agents acting against ecto-parasites\n2.2.4.\u00a0\u00a0\u00a0Acyl urea derivatives\nPharmacologically active substance(s) Marker residue Animal species MRLs Target tissues\n\u2018Fluazuron Fluazuron Bovine\u00a0(1) 200\u00a0\u03bcg/kg Muscle\n7\u00a0000\u00a0\u03bcg/kg Fat\n500\u00a0\u03bcg/kg Liver\n500\u00a0\u03bcg/kg Kidney\nB.\u00a0\u00a0\u00a0The following substances are inserted in Annex II to Regulation (EEC) No 2377/90:\n1.\u00a0\u00a0\u00a0Inorganic chemicals\nPharmacologically active substance(s) Animal species\n\u2018Sodium nitrite Bovine\u00a0(2)\n2.\u00a0\u00a0\u00a0Organic compounds\nPharmacologically active substance(s) Animal species\n\u2018Peforelin Porcine\u2019\n(1)\u00a0\u00a0Not for use in animals from which milk is produced for human consumption.\u2019\n(2)\u00a0\u00a0For topical use only.\u2019"}